Helash, who joins Marrone Bio from biological crop input provider Agrinos, says growing sales of its row crop treatments and other fungicides lead to the increase. He adds he's excited to take the company to its next level of success.
Marrone Bio Innovations new CEO Kevin Helash reveals uptick in quarterly earnings
Quick facts: Marrone Bio Innovations
Price: 1.18 USD
Market Cap: $176.26 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE